✓ Translated by DotMD AI Clinical Council Source: Obesity surgery • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #31925727 ↗

Randomized Controlled Trial: Sleeve Gastrectomy and Gastric Bypass Decrease the Carotid Intima-Media Thickness in Obese Men: Association with Weight Loss, Cardiovascular Risk Factors, and Circulating Testosterone

Original Paper Title: “Sleeve Gastrectomy and Gastric Bypass Decrease the Carotid Intima-Media Thickness in Obese Men: Association with Weight Loss, Cardiovascular Risk Factors, and Circulating Testosterone”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Both RYGB and SG decrease carotid IMT in men with obesity compared with conventional treatment with diet and exercise.
  • Study Design & Sample: Randomized Controlled Trial published in Obesity surgery (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Obesity surgery (2020), this randomized controlled trial evaluating human clinical outcomes investigated: Obesity surgery has shown to decrease the carotid intima-media thickness (IMT), but studies that compare different surgical techniques are scarce, especially in men. Key clinical takeaway: Both RYGB and SG decrease carotid IMT in men with obesity compared with conventional treatment with diet and exercise.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Obesity surgery, 2020-03-15; Randomized Controlled Trial; Rigor 82/100): Both RYGB and SG decrease carotid IMT in men with obesity compared with conventional treatment with diet and exercise.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 31925727: Randomized Controlled Trial: Sleeve Gastrectomy and Gastric Bypass Decrease the Carotid Intima-Media Thickness in Obese Men: Association with Weight Loss, Cardiovascular Risk Factors, and Circulating Testosterone

3 of 3 Free Questions Remaining